Chemoinformaics analysis of 4,6,6-Trimethylbicyclo[3.1.1]hept-2-en-4-ol
| Molecular Weight | 152.237 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 8 |
| Exact Molecular Weight | 152.12 | nRing | 3 |
| Solubility: LogS | -2.514 | nHRing | 0 |
| Solubility: LogP | 2.517 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.526 |
| Synth | 5.12 |
| Natural Product Likeliness | 2.712 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.291 |
| MDCK | 0.0000276 |
| BBB | 0.993 |
| PPB | 0.6007 |
| VDSS | 1.255 |
| FU | 0.5129 |
| CYP1A2-inh | 0.039 |
| CYP1A2-sub | 0.496 |
| CYP2c19-inh | 0.093 |
| CYP2c19-sub | 0.832 |
| CYP2c9-inh | 0.066 |
| CYP2c9-sub | 0.394 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.339 |
| CYP3a4-inh | 0.158 |
| CYP3a4-sub | 0.316 |
| CL | 8.755 |
| T12 | 0.25 |
| hERG | 0.003 |
| Ames | 0.004 |
| ROA | 0.066 |
| SkinSen | 0.045 |
| Carcinogencity | 0.041 |
| EI | 0.942 |
| Respiratory | 0.823 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.927852 |